HAWAII BIOTECH GROUP has a total of 46 patent applications. Its first patent ever was published in 1990. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are THE US SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, IDM PHARMA INC and INST PASTEUR SHANGHAI CAS.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 11 | |
#2 | WIPO (World Intellectual Property Organization) | 11 | |
#3 | United States | 9 | |
#4 | Canada | 4 | |
#5 | EPO (European Patent Office) | 4 | |
#6 | Israel | 3 | |
#7 | Brazil | 2 | |
#8 | China | 1 | |
#9 | Portugal | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Organic fine chemistry | |
#6 | Chemical engineering |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Climate change adaptation technologies | |
#6 | Analysing materials | |
#7 | Measuring microorganism processes | |
#8 | Steroids | |
#9 | Separation | |
#10 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Ivy John M | 15 |
#2 | Grothaus Paul G | 14 |
#3 | Bignami Gary S | 10 |
#4 | Mcdonell Michael | 10 |
#5 | Coller Beth-Ann G | 8 |
#6 | Clements David E | 8 |
#7 | Clements David | 6 |
#8 | Peters Iain | 5 |
#9 | Ivy John | 5 |
#10 | Coller Beth-Ann | 5 |
Publication | Filing date | Title |
---|---|---|
BR0013154A | Recombinant vaccine for the flavivirus infection envelope | |
US6569636B2 | Assay for modulators of metallo-enzyme activity | |
US6416763B1 | Recombinant nonstructural protein subunit vaccine against flaviviral infection | |
WO9906068A2 | Recombinant dimeric envelope vaccine against flaviviral infection | |
US6136561A | Methods of preparing carboxy-terminally truncated recombinant flavivirus envelope glycoproteins employing drosophila melanogaster expression systems | |
WO9637221A1 | Subunit vaccine against flavivirus infection | |
US6329191B1 | DNA encoding recombinant coffee bean alpha-galactosidase | |
EP0575556A1 | Palytoxin-related prodrugs and a method for their administration. | |
IL98311D0 | Process for affinity purification by immunoadsorption in non- aqueous solvents | |
WO9113971A1 | Neurospora expression system | |
US5118607A | Non-aqueous solvent specific binding protein assays | |
CA2028254A1 | Non-aqueous solvent specific binding protein assays |